Samir Kaul, Director at Guardant Health, Inc. (GH), sold 20,000 shares at $103.21 ($2.0M) on 2020-10-16, disclosed to the SEC on 2020-10-20.
Open-market sale of $2.0M GH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.29 | 5,210 | $528K | 25.9% |
| 2 | $101.29 | 5,210 | $528K | 25.9% |
| 3 | $102.19 | 3,215 | $329K | 16.1% |
| 4 | $102.19 | 3,215 | $329K | 16.1% |
| 5 | $103.21 | 1,575 | $163K | 8.0% |
| 6 | $103.21 | 1,575 |
| $163K |
| 8.0% |
| Total | $101.88 avg | 20,000 | $2.0M | 100% |
| Filing → |
| GH | SELL | 2020-09-21 | $1.8M | — | Filing → |
| GH | SELL | 2020-08-19 | $1.7M | — | Filing → |
| GH | SELL | 2020-03-06 | $2.1M | — | Filing → |